[ad_1]
Article content continued
Steve Tymchuk, CEO of Ebbtides, said the 15-year-old company specialized in extracorporeal life support and cardiac surgery products.
“We are excited to make CytoSorb immediately available during the COVID-19 crisis in Canada under Health Canada’s COVID-19 Medical Device Authorization for Importation and Sale,” Tymchuk wrote.
CytoSorb spokesperson Bernardo Soriano said the devices performed “extracorporeal blood purification”, “taking blood from a patient’s body, removing harmful inflammatory substances and then returning it.
“High levels of these substances, called cytokines cause problems for the immune system.
“The proteins that are removed are typically elevated during infections and can be associated with a ‘cytokine storm’ that occurs in some COVID-19 patients, leading to severe inflammation, rapidly progressive shock, respiratory failure, organ failure and death.”
Cytokine storm is a common death for COVID-19 patients.
dcarrigg@postmedia.com
[ad_2]
Source link
